drugset / Trial / NCT04476173

ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction

NCT04476173

Phase 3 Unknown 200 enrolled Collegium Medicum w Bydgoszczy
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate analgesic efficacy of inhaled methoxyflurane vs intravenous morphine in patients presenting with acute ST-elevation (STEMI) / non ST-elevation acute coronary syndrome (NSTE-ACS)

Timeline

Start
2020-06-01
Primary completion
2024-06-30
Completion
2024-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Methoxyflurane Small molecule 3 mg Inhaled
Comparator Morphine Other / unclassified 5 mg Intravenous